....AstraZeneca is not committing to manufacturing expansion in the UK as it waits for clarity on the government’s Brexit plans. Last month, its chief executive, Pascal Soriot
, said the company would “wait to see” before committing itself to further investment in Britain because of uncertainty in the pharmaceutical industry following the vote to leave the EU, in particular over the regulatory regime for new medicines. ...
[Read full article on Guardian
Sunday 27th of August 2017 01:31:50 PM